Patterns of metastasis and prognosis of BC molecular subtypes.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dana Haddad, MD, PhD
Radiologist, UAE

New treatments and perspectives in metastatic TNBC with PARP Inhibitors.
Benjamin VERRET
Oncologist, Villejuif, France
How can genomics power personalized medicine through pathology?
Aaron HAN
pathologist, Dubai, UAE
Overview in High Risk Patient Screening
Dana Haddad

MD, PhD, American Board Certified consultant breast radiologist

and Head of Breast Imaging at Healthbay Polyclinic in Dubai, UAE
What are the goals of AROME?
Jospeh GLIGOROV
oncologist, Paris, France
Radiotherapy schedules and techniques to solve the lack of tools in LMICs.
Yazid BELKACEMI

New treatments and perspectives in metastatic TNBC with PARP Inhibitors.